Professor Lara-Díaz obtained his M.D. Degree with honors at Universidad de Monterrey, in February 1982. He then pursued the Medical Residency in Pediatrics and obtained the degree of Specialist in Pediatrics in 1990, granted by Universidad Autónoma de NL, also in Monterrey, NL, México. He completed the Fellowship in Neonatology and obtained the degree of Specialists in Neonatology, by Universidad de Monterrey, in 2004. From 1988 to October 2003 Dr. Lara-Díaz was an Associate Professor of Pediatrics and later of Pediatrics and Neonatology, at Hospital Conchita, affiliated to Medical School of Universidad de Monterrey. Since February 2006 he is Professor at Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, he was the founder and academic director of the Neonatology Fellowship of the Multicentric Medical Residency Programs of Tecnológico de Monterrey and Secretaría de Salud, until February 28, 2019 in Monterrey, NL, México. On May 2007, he obtained the master's degree in Medical Sciences and Biotechnology, at Tecnológico de Monterrey, in Monterrey, NL, México. Later, Dr. Lara-Díaz pursued a second Master of Sciences and a Doctoral degree, focused on Molecular Medicine applied to Oxidative Stress and Bio Protection, both at CEU-Universidad San Pablo, Madrid Spain, completed in 2013, with Cum Laude. He is currently affiliated to the Strategic Research Focus Group on Human Genetics at Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey.
He has collaborated as a reviewer for Universitas.Scientiarium of the Pontificia Universidad Javeriana, Bogotá, Colombia; Global Journal of Health Science, from the Canadian Center of Science and Education; Journal of Biological Regulators and Homeostatic Agents, from Biolifesas.org ; American Journal of Perinatology, Thieme, Germany and UK , European Journal of Pediatrics, Springer Link, Berlin; Pediatric Research, Nature Publishing Group, official publication of the American Pediatric Society, the European Society for Pediatric Research and the Society for Pediatric Research; Italian Journal of Pediatrics and Panamerican Journal of Public Health, by the Pan American Health Organization (PAHO), headquartered in Washington, DC, the United States of America.
He is Associate Editor of Tratado de Pediatria, published in 2017 in Madrid, by CTO editorial, where he contributed to five chapters, and has published 26 scientific communications, indexed in Scopus, where he currently has an H index of 6, and participated in numerous medical national meetings as a speaker. He has also developed an Electronic Health Record application, focused on the Pediatrics field, along with another partner. His current research efforts are focused on the study of caffeine metabolism in the preterm neonate; search of biomarkers and potential therapeutic targets for bronchopulmonary dysplasia; studies on toxicology and substance abuse in adolescent pregnancy; search of biomarkers for the early detection of fetal alcoholism spectrum; and search for early detection of late-onset neonatal sepsis through novel micro-electronic devices. His areas of interest in teaching lie on Neonatology, Molecular Medicine applied to Neonatology, Medical Research methodology, and Ethics in Medical Research.
Dr. Lara-Díaz is member of multiple professional organizations founder member and past-president of Sociedad de Neonatología del Estado de NL, AC; Current member of Federación Nacional de Neonatología de México, AC; past-president and counselor for Consejo Mexicano de Certificación en Pediatría, Sección Neonatología AC; numerar member of Academia Mexicana de Pediatría AC; and member of Conacyt National Researchers Council (Level I). He is in active clinical practice, strongly involved in translational medical research and postgraduate medical teaching. He has conducted 18 medical specialty and 3 Clinical Sciences doctoral theses in Tecnológico de Monterrey affiliated programs